Nos publications
High Drug Load Lipid Matrix Tablets Prepared by Wet Granulation: PART I – Formulation Parameters
AAPS Annual Meeting and Exposition - San Antonio (USA) - nov 2013
Sustained release levadopa mini-tablets containing Compritol® 888: a viable approach for special patient populations
AAPS Annual Meeting and Exposition – San Antonio (USA) - nov 2013
Percolation threshold of Compritol® 888 in matrix tablets: assessing the minimum concentration to create an infinite lipid network
AAPS Annual Meeting and Exposition – San Antonio (USA) - nov 2013
Compritol®888 ATO a lipid excipient for sustained release of highly water soluble active: formulation, scale-up and IVIVC study.
Curr Drug Deliv. 2013 Oct;10(5):548-56. - oct 2013
Lipid matrix by hot melt extrusion: a practical industrial solution for solid dispersion
AAPS Annual Meeting & Exposition – Chicago (USA) - nov 2012
Synergic effect of two glycerides to increase stability and ethanol resistance of sustained release matrix tablets
AAPS Annual Meeting & Exposition – Chicago (USA) - oct 2012
Compritol® 888 ATO lipid matrices for sustained release processed by hot melt extrusion
CRS Annual Meeting – Québec (Canada) - jui 2012
Performance of a Compritol® 888 ATO lipid matrix tablet to deliver sustained release of diclofenac sodium
CRS Annual Meeting – National Harbor (USA) - jui 2011
Formulation Effects on Drug Release from Sustained-Release Compritol® 888 ATO Tablets and Mini-Tablets
CRS Annual Meeting – National Harbor (USA) - jui 2011